Severe injection site reaction to insulin detemir [3]

Diabetes Care

Volumn 29, Issue 4, 2006, Pages 946-

  Blumer, Ian R ^a,b  

^a Charles H Best Diabetes Centre   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN DETEMIR; ISOPHANE INSULIN;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INJECTION SITE REACTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LETTER; SKIN DEFECT; SKIN INDURATION;

EID: 33746352091     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.04.06.dc05-2503     Document Type: Letter

References (2)

1. European Medicines Agency: Levemir European Public Assessment Report, Levemir-H-528-II-01 [article online], 2003. Available at http://www.emea.eu.int/ humandocs/Humans/EPAR/levemir/levemir.htm. Accessed 19 December 2005
2. Darmon P, Castera V, Koeppel M, Petitjean C, Dutour A: Type III allergy to insulin detemir (Letter). Diabetes Care 28: 2980, 2005